Now Enrolling: SkinBetter Science Clinical Study

Skinbetter Science study evaluating the safety, efficacy, tolerability and subject satisfaction with a topical skincare formula called AHARet to counteract certain visible signs of aging. AHARet (AlphaRet® Overnight Cream) is a currently available and marketed topical, double conjugated retinoid/alpha hydroxy acid cream.

Your participation in this study will last approximately 14 weeks and will consist of approximately six (6) study visits to the study site including this initial (screening) visit.

• Females 40-65 years of age
• Must have mild to moderate photoaged skin
• Self-perceived sensitivity, poor tolerability or skin irritation experienced with topical prescription or non-prescription vitamin A derivatives (retinol, tretinoin, or other retinoids) other than AlphaRet® in which the subject could not use the product as instructed or had to discontinue use
• Nonsmoker (tobacco, electronic cigarettes/vaping devices, and cannabis)
• No prior use of Skinbetter Science AlphaRet® facial products
• No prior use of Accutane

If you meet the critera above and are eligible to participate, apply here: https://forms.gle/2A4bKd3ptEn1Bqm97